E-therapeutics forms pact to tackle neurodegenerative diseases

14:42 13/08/2019
StockMarketWire.com - E-therapeutics said it had agreed to work with a global 'top five' pharmaceutical company on a project in a specific area of biology associated with neurodegenerative diseases.

Under the 12-month agreement, E-therapeutics said it would use its drug discovery approach to identify novel disease pathways and small molecules. Neurodegeneration occurred when there was progressive loss of structure or function of neurons.

It could lead to a number of debilitating diseases such as Parkinson's, Alzheimer's and Huntington's.

'We are thrilled to be working with one of the largest global pharma companies in an exciting area of disease biology where there is a significant unmet need,' chief executive Ray Barlow said.

At 2:42pm: (LON:ETX) eTherapeutics PLC share price was -0.1p at 2.4p


Story provided by StockMarketWire.com

Forex

Commodities

What the Papers Say

telegraph financial times daily mail daily express independent times
21:39 FirstFT: Today’s top stories 
source: FT.com
21:33 PG&E sinks to 7-month low on new wildfire...
source: FT.com
21:30 Wall Street rises for third day while...
source: FT.com
20:09 China social media accounts suspended over...
source: FT.com
19:48 Banking bodies look at shorter trading day...
source: FT.com
19:47 Hong Kong billionaire to buy pub group...
source: FT.com
19:46 Royal Mail accord with workers is...
source: FT.com
19:45 Markets rally despite new Germany...
source: The Guardian
19:20 Saxo chief predicts more fintech takeovers
source: FT.com
19:16 Auction blunder sees sale of oldest...
source: The Daily Mail
[more ...]